Nordic Market Access Nma Ab
Nordic Market Access is a Stockholm-based pharma consultancy founded in 2020 that delivers market access strategy, health economic modelling, real-world evidence, and country dossier services to pharmaceutical and life sciences clients across Sweden, Denmark, Norway, and Finland.
- Company typePrivate
- Founded2020
- HeadquartersStockholm, Sweden
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Nordic Market Access Nma Ab does
Nordic Market Access NMA AB is a privately held Stockholm-based consultancy founded in 2020 that specializes in market access, health economics, and data analytics for pharmaceutical and life sciences clients. Its service portfolio spans market access strategy development, health economic modelling (cost-effectiveness, utility, and budget impact analyses), real-world data and advanced analytics, access pathway mapping, and country-specific dossier development. Since founding, the firm reports delivery of more than 400 projects, 130+ tailored model adaptations, 90+ country dossiers, and 80+ strategy projects, with named case work referencing Nordic expansion support for clients such as BioNordic Pharma.
The underlying offering combines health technology assessment (HTA) expertise with real-world evidence (RWE) generation, applied across therapeutic areas ranging from rare diseases to primary care products and operating across Sweden, Denmark, Norway, and Finland. The business model is professional services on a project-based, quote-priced engagement structure delivered through direct client relationships and senior-led consulting, with go-to-market supported by LinkedIn presence, industry event participation (e.g., SHEA), and a recently relaunched content-driven website. The named team is small (approximately five professionals) with credentials concentrated at Lund, Uppsala, and the University of Aberdeen in economics and health economics, supplemented by prior experience at the Swedish Association of the Pharmaceutical Industry (LIF).
Revenue, ownership structure, and headcount beyond named professionals are not publicly disclosed; no external funding rounds, M&A activity, patents, certifications, or AI/ML capabilities are documented in the available source material.
Nordic Market Access Nma Ab firmographics
Firmographics- Name
- Nordic Market Access Nma Ab
- Legal name
- Nordic Market Access
- Website
- https://nordicmarketaccess.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nordic Market Access is a Stockholm-based pharma consultancy founded in 2020 that delivers market access strategy, health economic modelling, real-world evidence, and country dossier services to pharmaceutical and life sciences clients across Sweden, Denmark, Norway, and Finland.
- Ownership category
- akta.pro rank
Nordic Market Access Nma Ab industry classification
Industry- Product category
- Pharmaceutical Market Access Consulting
- NAICS
- Marketing Research and Public Opinion Polling (541910)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Health Supply Chain, Procurement & Access to Medicines (BPADAIAI)
- akta.pro secondary industry
- Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines) (HLAJAOAK)
Keywords
Where Nordic Market Access Nma Ab is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Nordic Market Access Nma Ab business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Consulting Services: Professional consulting services in market access, health economics, and data analytics. Services include strategy development, dossier creation, health-economic modeling, and real-world evidence generation. Revenue is generated through project-based engagements with pharmaceutical and life sciences clients across the Nordic region and globally.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Nordic Market Access Nma Ab product offering
Product offeringCore offering
Nordic Market Access is a consultancy firm that delivers market access, health economics, and data analytics services to pharmaceutical and life sciences companies. It provides market access strategy development, health-economic modelling (cost-effectiveness, utility, budget impact), real-world evidence generation and analytics, access pathway mapping, and country-specific HTA dossier development to support product launches and reimbursement across the Nordic region and internationally.
Product overview
Nordic Market Access is a consultancy agency specializing in Market Access, health economics, and data analytics. They offer a unified service portfolio spanning strategy development to implementation, including market access strategy development, health economic modelling (cost-effectiveness, utility, and budget impact), real-world data and advanced analytics for HTA success, access pathway mapping, and country dossier development. Their services work together to provide comprehensive support from early strategy through to dossier and tool delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Market Access Strategy Development
- Health Economic Modelling
- Real-World Data and Analytics
- Access Pathway Mapping
- Country Dossier Development
Quantifiable outcome
- 400+ projects delivered worldwide since 2020
- +3 more outcomes
Companies that use Nordic Market Access Nma Ab
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Nordic Market Access Nma Ab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Nordic Market Access Nma Ab partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights4 records
Nordic Market Access Nma Ab competitors and assessment
Company assessmentBroad incumbents
- PAREXEL International: Global CRO and consulting firm with a market access and HEOR consulting practice. Comparable to NMA on reimbursement strategy and payer engagement, but operates as a much broader incumbent with integrated clinical and regulatory capabilities.
- ICON plc: Global clinical research organization with a market access and HEOR consulting arm following the PRA Health Sciences and Symphony Health integrations. Competes with NMA on value communications, HTA, and health economics across pharma clients worldwide.
- IQVIA: Largest healthcare data, analytics, and consulting provider with a global market access and HEOR practice. Overlaps with NMA across HTA, real-world data, and pricing work but competes as a broad incumbent with proprietary data assets and significantly greater scale.
Emerging players
- Certara: Regulatory and market access sciences company offering HEOR, HTA, and real-world evidence services — historically through its Analytica acquisition. Competitor to NMA on health-economic modelling, value dossiers, and payer evidence generation.
- Charles River Associates (CRA): Consulting firm with a Life Sciences practice covering market access, pricing, and health economics. Comparable to NMA on access strategy work, though CRA operates as a broader economics and management consultancy.
Direct peers
- Evidera: Multi-specialty HEOR, market access, and RWE consulting firm serving global pharma. Directly comparable because its service portfolio (HTA submissions, health-economic modelling, value communications, real-world evidence) is essentially the same as NMA's, scaled to a global client base.
- Putnam Associates: Specialist pharma and life sciences strategy consulting firm focused on market access, pricing, and commercial strategy. Closely aligned with NMA in serving global pharma on launch readiness, payer strategy, and value evidence.
- Simon-Kucher & Partners: Global strategy consulting firm with a dedicated Life Sciences practice focused on pharma pricing, market access, and value strategy. Comparable to NMA on access strategy, payer value proposition development, and pricing for launches across therapeutic areas.
- PharmaLex (Cencora): Regulatory, market access, and pharmacovigilance consulting firm now part of Cencora, serving global pharma with services spanning HTA submissions, pricing, and payer engagement. Directly comparable to NMA's market access and HTA capabilities.
Regional players
- Nordic Health Group (NHG): Stockholm-based Nordic health economics and outcomes research consultancy serving pharma and medtech clients across Sweden and the broader Nordics. Direct regional peer to NMA on HTA, market access, and health-economic modelling in the same geography.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights6 records
Customer concentration
Nordic Market Access Nma Ab social profiles
Digital presenceNordic Market Access Nma Ab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nordic Market Access Nma Ab leadership team
Management profileNumber of profiles
Profiles5 records
Nordic Market Access Nma Ab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nordic Market Access Nma Ab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nordic Market Access Nma Ab
What does Nordic Market Access Nma Ab do?
Nordic Market Access is a consultancy firm that delivers market access, health economics, and data analytics services to pharmaceutical and life sciences companies. It provides market access strategy development, health-economic modelling (cost-effectiveness, utility, budget impact), real-world evidence generation and analytics, access pathway mapping, and country-specific HTA dossier development to support product launches and reimbursement across the Nordic region and internationally.
Is Nordic Market Access Nma Ab a public or private company?
Nordic Market Access Nma Ab is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nordic Market Access Nma Ab founded?
Nordic Market Access Nma Ab was founded in 2020. It employs 1 to 10 people.
Where is Nordic Market Access Nma Ab based?
Nordic Market Access Nma Ab is headquartered in Stockholm, Sweden, in the Europe region.
How does Nordic Market Access Nma Ab make money?
One revenue line is on record: consulting Services.
Who are Nordic Market Access Nma Ab's main competitors?
Broad incumbents on record are PAREXEL International, ICON plc and IQVIA. Emerging players are Certara and Charles River Associates (CRA). Direct peers are Evidera, Putnam Associates, Simon-Kucher & Partners and PharmaLex (Cencora). Nordic Health Group (NHG) is listed as a regional player.
Does Nordic Market Access Nma Ab have an API?
No public API is recorded for Nordic Market Access Nma Ab.
What industry is Nordic Market Access Nma Ab in?
Nordic Market Access Nma Ab's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is BPADAIAI, Health Supply Chain, Procurement & Access to Medicines, with a secondary code of HLAJAOAK, Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines). Its NAICS code is 541910 and its SIC code is 8000.